Laurène Pousse

Laurène Pousse

Auto-generated profile, based on publicly available information

Laurène Pousse

Roche Innovation Center Zurich (RICZ)

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2025 in mAbs
Verified
Journal Article
Open access
LPLaurène Pousse
Laurène Pousse
AMAmrita Manchala
Amrita Manchala
Christian KleinChristian Klein
Christian Klein
LDLaura Codarri Deak
Laura Codarri Deak
First-generation cancer immunotherapies, such as high-dose interleukin-2 (IL-2), have demonstrated clinical efficacy, but are limited by significant systemic toxicities due to their broad expression of cytokine receptors. This has driven the iterative development of targeted cytokine delivery strategies. Early efforts focused on receptor-biased IL-2 variants designed to attenuate or abrogate IL-2 receptor α (IL-2 Rα/CD25) binding. Subsequently, the concept of "cis-targeting" has emerged as a strategy to deliver cytokines to specific immune cell populations, enhancing anti-tumor responses while mitigating systemic toxicity. This review highlights key common γ-chain cytokines (IL-2, IL-7, IL-15, and IL-21) as well as IL-12, providing an overview of their structures, receptors, as well as their distinct T cell functions. Furthermore, we specifically focus on the current landscape of engineered cytokine variants that facilitate targeted cytokine delivery in cis to specific T cells. By successfully restricting cytokine activity to specific T cell populations, cis-targeting approaches represent a promising strategy in the field, enabling efficient immunotherapies with improved tolerability and enhanced anti-tumor responses.

20 May 2024 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SBSara Belli
Sara Belli
MAMaria Amann
Maria Amann
LHLucy Hutchinson
Lucy Hutchinson
LPLaurène Pousse
Laurène Pousse
AAAfsaneh Abdolzade‐Bavil
Afsaneh Abdolzade‐Bavil
EMEstelle Marrer‐Berger
Estelle Marrer‐Berger